ZA816549B - 3-aryl-5-isothiazolecarboylic acids and related compounds to lower uric acid levels - Google Patents
3-aryl-5-isothiazolecarboylic acids and related compounds to lower uric acid levelsInfo
- Publication number
- ZA816549B ZA816549B ZA816549A ZA816549A ZA816549B ZA 816549 B ZA816549 B ZA 816549B ZA 816549 A ZA816549 A ZA 816549A ZA 816549 A ZA816549 A ZA 816549A ZA 816549 B ZA816549 B ZA 816549B
- Authority
- ZA
- South Africa
- Prior art keywords
- isothiazolecarboylic
- aryl
- acids
- uric acid
- related compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/189,435 US4346094A (en) | 1980-09-22 | 1980-09-22 | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA816549B true ZA816549B (en) | 1983-04-27 |
Family
ID=22697314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA816549A ZA816549B (en) | 1980-09-22 | 1981-09-21 | 3-aryl-5-isothiazolecarboylic acids and related compounds to lower uric acid levels |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4346094A (ro) |
| EP (1) | EP0048615B1 (ro) |
| JP (1) | JPS5785379A (ro) |
| KR (1) | KR830007597A (ro) |
| AR (1) | AR229103A1 (ro) |
| AT (1) | ATE7657T1 (ro) |
| AU (1) | AU7551681A (ro) |
| CS (1) | CS228536B2 (ro) |
| DD (1) | DD201790A5 (ro) |
| DE (1) | DE3163900D1 (ro) |
| DK (1) | DK417981A (ro) |
| ES (1) | ES8301225A1 (ro) |
| FI (1) | FI812940L (ro) |
| GB (1) | GB2084573B (ro) |
| GR (1) | GR75046B (ro) |
| IL (1) | IL63890A0 (ro) |
| NO (1) | NO813208L (ro) |
| PL (1) | PL130497B1 (ro) |
| PT (1) | PT73711B (ro) |
| RO (1) | RO82216A (ro) |
| YU (1) | YU227181A (ro) |
| ZA (1) | ZA816549B (ro) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428956A (en) | 1980-12-29 | 1984-01-31 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4431652A (en) * | 1980-12-29 | 1984-02-14 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4539328A (en) * | 1983-03-25 | 1985-09-03 | Fmc Corporation | Nematicidal isothiazole derivatives |
| US4620865A (en) * | 1983-11-07 | 1986-11-04 | Eli Lilly And Company | Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| ZW21687A1 (en) * | 1986-12-12 | 1988-07-20 | Hoffmann La Roche | Triazine derivatives |
| ATE142494T1 (de) * | 1990-11-30 | 1996-09-15 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
| US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
| US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
| MY117352A (en) * | 1995-10-31 | 2004-06-30 | Ciba Sc Holding Ag | Oximesulfonic acid esters and the use thereof as latent sulfonic acids. |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| WO1999024038A1 (en) | 1997-11-07 | 1999-05-20 | Johns Hopkins University | Methods for treatment of disorders of cardiac contractility |
| TW575792B (en) * | 1998-08-19 | 2004-02-11 | Ciba Sc Holding Ag | New unsaturated oxime derivatives and the use thereof as latent acids |
| SG78412A1 (en) | 1999-03-31 | 2001-02-20 | Ciba Sc Holding Ag | Oxime derivatives and the use thereof as latent acids |
| CN100475798C (zh) | 2002-02-06 | 2009-04-08 | 西巴特殊化学品控股有限公司 | 磺酸衍生物及其作为潜酸的用途 |
| WO2006022374A1 (ja) * | 2004-08-27 | 2006-03-02 | Astellas Pharma Inc. | ２－フェニルピリジン誘導体 |
| WO2006022375A1 (ja) * | 2004-08-27 | 2006-03-02 | Astellas Pharma Inc. | ２－フェニルチオフェン誘導体 |
| DE602006018635D1 (de) | 2005-10-07 | 2011-01-13 | Astellas Pharma Inc | Triarylcarbonsäurederivat |
| EP1992361B1 (en) | 2006-02-24 | 2012-05-02 | Astellas Pharma Inc. | Remedy or preventive for digestive ulcer |
| GB2450975B (en) | 2007-07-12 | 2010-02-24 | Ciba Holding Inc | Yellow radiation curing inks |
| CN102333765B (zh) | 2009-02-27 | 2015-01-14 | 帝人制药株式会社 | 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法 |
| WO2010112408A1 (en) | 2009-03-30 | 2010-10-07 | Basf Se | Uv-dose indicator films |
| SG187843A1 (en) | 2010-08-27 | 2013-03-28 | Teijin Pharma Ltd | Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound |
| KR101897842B1 (ko) | 2011-01-28 | 2018-09-12 | 바스프 에스이 | 열 경화제로서 옥심 술포네이트를 포함하는 중합성 조성물 |
| EP2980085B1 (en) | 2013-03-29 | 2018-03-14 | Teijin Pharma Limited | Pyrazole derivative |
| CN106604912A (zh) | 2014-08-29 | 2017-04-26 | 巴斯夫欧洲公司 | 肟磺酸酯衍生物 |
| WO2016174043A1 (de) | 2015-04-29 | 2016-11-03 | Bsn Medical Gmbh | Mehrstufiges verfahren zur no-herstellung |
| BR112017023170B1 (pt) | 2015-04-29 | 2022-08-16 | Bsn Medical Gmbh | Dispositivo de banho medicinal e seu uso |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1178604A (en) * | 1966-03-21 | 1970-01-21 | American Cyanamid Co | Novel Pyridinium Salts and Methods for Preparing Same |
| US3464999A (en) * | 1967-07-27 | 1969-09-02 | R & L Molecular Research Ltd | Thiadiazolylisothiazoles |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| GB1192701A (en) * | 1968-03-22 | 1970-05-20 | Ici Ltd | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
| US3681498A (en) * | 1970-10-19 | 1972-08-01 | American Cyanamid Co | Isothiazolyl pyridinium salts as hypoglycemic agents |
-
1980
- 1980-09-22 US US06/189,435 patent/US4346094A/en not_active Expired - Lifetime
-
1981
- 1981-09-19 PL PL1981233103A patent/PL130497B1/pl unknown
- 1981-09-20 IL IL63890A patent/IL63890A0/xx unknown
- 1981-09-21 DE DE8181304325T patent/DE3163900D1/de not_active Expired
- 1981-09-21 AU AU75516/81A patent/AU7551681A/en not_active Abandoned
- 1981-09-21 DK DK417981A patent/DK417981A/da not_active Application Discontinuation
- 1981-09-21 NO NO813208A patent/NO813208L/no unknown
- 1981-09-21 YU YU02271/81A patent/YU227181A/xx unknown
- 1981-09-21 GR GR66108A patent/GR75046B/el unknown
- 1981-09-21 PT PT73711A patent/PT73711B/pt unknown
- 1981-09-21 FI FI812940A patent/FI812940L/fi not_active Application Discontinuation
- 1981-09-21 AT AT81304325T patent/ATE7657T1/de not_active IP Right Cessation
- 1981-09-21 AR AR286818A patent/AR229103A1/es active
- 1981-09-21 RO RO81105346A patent/RO82216A/ro unknown
- 1981-09-21 GB GB8128465A patent/GB2084573B/en not_active Expired
- 1981-09-21 EP EP81304325A patent/EP0048615B1/en not_active Expired
- 1981-09-21 ZA ZA816549A patent/ZA816549B/xx unknown
- 1981-09-21 ES ES505678A patent/ES8301225A1/es not_active Expired
- 1981-09-22 DD DD81233487A patent/DD201790A5/de unknown
- 1981-09-22 JP JP56150483A patent/JPS5785379A/ja active Pending
- 1981-09-22 KR KR1019810003537A patent/KR830007597A/ko unknown
- 1981-09-22 CS CS816978A patent/CS228536B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4346094A (en) | 1982-08-24 |
| EP0048615B1 (en) | 1984-05-30 |
| IL63890A0 (en) | 1981-12-31 |
| AR229103A1 (es) | 1983-06-15 |
| RO82216A (ro) | 1983-07-07 |
| PT73711B (en) | 1982-12-20 |
| PT73711A (en) | 1981-10-01 |
| ATE7657T1 (de) | 1984-06-15 |
| EP0048615A1 (en) | 1982-03-31 |
| GB2084573B (en) | 1984-09-12 |
| CS228536B2 (en) | 1984-05-14 |
| ES505678A0 (es) | 1982-12-01 |
| DE3163900D1 (en) | 1984-07-05 |
| ES8301225A1 (es) | 1982-12-01 |
| KR830007597A (ko) | 1983-11-04 |
| PL130497B1 (en) | 1984-08-31 |
| GB2084573A (en) | 1982-04-15 |
| GR75046B (ro) | 1984-07-12 |
| RO82216B (ro) | 1983-06-30 |
| JPS5785379A (en) | 1982-05-28 |
| DK417981A (da) | 1982-03-23 |
| NO813208L (no) | 1982-03-23 |
| FI812940L (fi) | 1982-03-23 |
| PL233103A1 (ro) | 1982-12-20 |
| AU7551681A (en) | 1982-04-01 |
| DD201790A5 (de) | 1983-08-10 |
| YU227181A (en) | 1983-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA816549B (en) | 3-aryl-5-isothiazolecarboylic acids and related compounds to lower uric acid levels | |
| ZA818908B (en) | Preparation of carboxylic acid | |
| GB2075506B (en) | Thioxanthonecarboxylic acids and thioxanthonecarboxylic acid derivatives | |
| GB2071665B (en) | 18-glycyrrhizinic acid | |
| IL56430A (en) | Prostenoic acid esters of 17-hydroxyalkanoyloxyestratrienes or 21-hydroxyalkanoyloxypregnenes | |
| JPS5714570A (en) | Preparation of n-benzyloxycarbonylaspartic acid | |
| DE3267782D1 (en) | 3-methylflavone-8-carboxylic acid esters | |
| GB2102415B (en) | Apovincaminic acid esters | |
| GB2049180B (en) | Bilirubin-resistant determination of uric acid | |
| JPS5724396A (en) | Manufacture of diacetone-ketogulonic acid | |
| JPS57149264A (en) | Manufacture of 1-alkyl-2-chloro-5-nitro-4- benzole-sulfonic acid | |
| DE3562245D1 (en) | Esters of 2-bromo-4-methylimidazole-5-carboxylic acid | |
| JPS56169644A (en) | Manufacture of alkoxyalkanoic acid | |
| GB2110208B (en) | Vincaminic acid esters | |
| HK74987A (en) | Esters of 2-carbamoyloxymethyl-6-hydroxyethyl-2-penem-3-carboxylic acid | |
| GB2018989B (en) | Uric acid standard solutions | |
| IL66413A0 (en) | Preparation of alpha-hydroxyphophonic acid esters | |
| GB8504116D0 (en) | Preparation of acid esters | |
| JPS56104848A (en) | Manufacture of 11nitrobenzenee22carboxylic acid alkylesterr55carboxylic acid | |
| JPS5793925A (en) | Manufacture of 2-methoxyalkanoic acid | |
| IL63720A0 (en) | Preparation of apovincaminic acid esters | |
| GB2085443B (en) | Calcitroic acid and related compounds | |
| JPS57136550A (en) | Manufacture of 6-dialkylresorcylic acid ester | |
| JPS5753478A (en) | N-carbonyl-n-methylcarbamic acid aryl ester and use thereof | |
| GB2086881B (en) | Esters of substituted benzoic acid |